HHLR ADVISORS, LTD. - Q1 2020 holdings

$7.42 Billion is the total value of HHLR ADVISORS, LTD.'s 60 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 33.3% .

 Value Shares↓ Weighting
ZM SellZOOM VIDEO COMMUNICATIONS INcl a$905,131,000
+92.3%
6,194,437
-10.4%
12.20%
+108.1%
TAL SellTAL EDUCATION GROUPsponsored ads$399,744,000
-27.7%
7,505,520
-34.5%
5.39%
-21.8%
ALGN SellALIGN TECHNOLOGY INC$185,527,000
-71.8%
1,066,551
-54.7%
2.50%
-69.4%
SE SellSEA LTDsponsored ads$55,388,000
-68.0%
1,250,000
-70.9%
0.75%
-65.4%
LN SellLINE CORPsponsored adr$41,942,000
-23.7%
871,256
-22.3%
0.56%
-17.5%
ZLAB SellZAI LAB LTDadr$28,430,000
-14.3%
552,256
-30.8%
0.38%
-7.3%
QCOM ExitQUALCOMM INC$0-200,000
-100.0%
-0.22%
NFLX ExitNETFLIX INC$0-136,400
-100.0%
-0.55%
EDU ExitNEW ORIENTAL ED & TECH GRP Ispon adr$0-603,208
-100.0%
-0.91%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q1 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings